At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Related Posts
Academy Pushes for Expanded Medicare Beneficiary Access
The Academy teamed up with the Academy of Doctors of Audiology (ADA) and the American Speech-Language-Hearing Association (ASHA) to push for expanded Medicare beneficiary access…
Medicare Resources for Providers and Suppliers in FEMA-Designated Disaster Zones
The Centers for Medicare and Medicaid Services (CMS) has announced the availability of accelerated and advanced Medicare payments for eligible providers and suppliers who are…
NCSB Annual Conference and ASLP-IC Progresses
This past weekend, the National Council of State Boards (NCSB), which represents audiology licensure boards, held its annual conference in San Antonio, Texas. In this…